TG Therapeutics, Inc. (TGTX) Income Annual - Discounting Cash Flows
TGTX
TG Therapeutics, Inc.
TGTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2008
12-31
2007
12-31
2006
12-31
2005
12-31
2004
12-31
2003
12-31
2002
12-31
2001
12-31
2000
12-31
1999
12-31
1998
12-31
1997
12-31
1996
12-31
Report Filing 2026-02-27 2026-02-27 2025-03-03 2024-02-29 2023-03-01 2022-03-01 2021-03-01 2020-03-02 2019-03-01 2018-03-15 2017-03-16 2016-03-15 2015-03-16 2014-03-07 2013-03-21 2012-03-14 2011-03-31 2010-03-31 2009-03-31 2008-03-31 2007-04-02 2006-03-31 2005-03-31 2004-04-02 2003-04-14 2002-04-01 2001-04-17 2000-03-30 1999-03-25 1998-03-23 1997-03-31
Revenue 616.3 616.3 329 233.7 2.79 6.69 0.152 0.152 0.152 0.152 0.152 0.152 0.152 0.152 0.019 0 0 0 0 0 0 0 0 0 0.5 2.71 5.36 1.2 3 0.1 0.1
Cost of Revenue 100.8 101 38.49 14.13 0.265 0.79 0 0 0.088 0.082 0.063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.08 4.06 0.8 -0.2 -0.1 0
Gross Profit 515.4 515.3 290.5 219.5 2.52 5.9 0.152 0.152 0.064 0.07 0.089 0.152 0.152 0.152 0.019 0 0 0 0 0 0 0 0 0 0.5 0.629 1.3 0.4 3.2 0.2 0.1
Operating Expenses 392.1 392 248.6 198.9 220.8 350.7 273.7 169.2 174.5 118.8 79.06 63.33 55.87 23.12 26.91 0.882 2.02 1.77 4.41 12.14 10 19.36 6.14 4.76 2.05 3.74 4.46 3.1 5.9 5.5 3.9
Research & Development 160.2 160.2 94.29 76.19 125.4 222.6 165.9 154.2 153.8 96.89 66.49 43.45 31.35 12.62 20.57 0.327 0.496 0.04 1.8 8.54 6.17 17.07 4.15 1.72 0.54 0.887 1.13 1.1 3 2.6 1.1
Selling, General and Administrative 231.9 231.8 154.3 122.7 95.48 128.1 107.8 15.03 15.16 16.33 9.89 15.63 15.79 6.66 4.78 0.555 1.52 1.73 2.61 3.61 3.83 2.29 1.99 1.79 1.51 2.85 3.26 1.9 2.7 2.8 2.8
Other Operating Expenses 0 -0 0 0 0 0 0 0 5.51 5.56 2.68 4.26 8.73 3.84 1.56 0 0 0 0 0 0 0 0 1.25 0 0 0.076 0.1 0.2 0.1 0
Operating Income 123.3 123.3 41.93 20.63 -218.3 -344.8 -273.6 -169.1 -174.4 -118.7 -78.97 -63.18 -55.72 -22.97 -26.9 -0.882 -2.02 -1.77 -4.41 -12.14 -10 -19.36 -6.14 -4.76 -1.55 -3.11 -3.16 -2.7 -2.7 -5.3 -3.8
Net Non-Operating Interest -26.73 -26.73 -24.03 -12.62 -10.19 -5.64 -6.33 -5.29 -0.877 -0.845 0.323 -0.798 -0.876 -0.922 -0.89 -0.007 -0.723 0.038 0.394 -0 -0.002 0 0 0 0 0 0 0 0 0 0
Interest Income 0 0 0 0 0 0 0 0 0.857 0.294 0.323 0.175 0.055 0.031 0.016 0 0.548 0.587 0.459 0 0 0 0 0 0 0 0 0 0 0 0
Interest Expense 26.73 26.73 24.03 12.62 10.19 5.64 6.33 5.29 1.73 1.14 0 0.973 0.931 0.953 0.906 0.007 1.27 0.548 0.065 0 0.002 0 0 0 0 0 0 0 0 0 0
Equity & Other Income/(Expense) 10.79 10.79 7.69 5.04 4.7 2.31 0.542 1.47 1.79 1.08 0.393 1.03 0.815 3.41 1.93 0 4.09 -1.1 -0.644 0.112 0.001 0.006 0.071 -2.46 -0.005 1.33 -2.73 2.7 2.7 0.2 0.2
Income Before Tax 107.4 107.4 25.59 13.06 -223.8 -348.1 -279.4 -172.9 -173.5 -118.5 -78.25 -62.95 -55.78 -20.48 -25.85 -0.889 1.35 -2.83 -4.66 -12.03 -10 -19.35 -6.07 -7.22 -1.56 -1.78 -5.9 0 0 -5.1 -3.6
Income Tax Expense -339.8 -339.8 2.21 0.39 0 0 0 0 -0.918 -0.236 -0.716 -0.231 0.06 -2.49 0.33 0 -2.64 1.02 -0.144 -0.112 -0.305 -0.216 -0.247 1.2 -0.006 -1.37 2.64 -0.3 0.1 0.1 0
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 0.918 0.236 0.716 0.231 -0.06 2.49 -8.11 -0.036 3.36 -1.06 -0.25 0.112 -0.001 0.006 0.071 -2.46 -0.005 1.33 -2.73 2.7 2.7 0 0
Net Income 447.2 447.2 23.38 12.67 -223.8 -348.1 -279.4 -172.9 -173.5 -118.5 -78.25 -62.95 -55.78 -20.48 -18.07 -0.853 0.624 -2.79 -4.27 -12.03 -9.7 -19.14 -5.9 -5.96 -1.55 -1.73 -5.8 -2.4 -2.8 -5.2 -3.6
Depreciation and Amortization 0.244 0.244 0.28 0.423 0.515 0.494 0.374 0.282 0.088 0.082 0.063 0.015 0.004 0.001 0 0.036 0.003 0.006 0.026 0.048 0.06 0.054 0.128 0.189 0.05 0.066 0.076 0.1 0.2 0.1 0.2
EBITDA 123.6 123.6 42.21 21.06 -217.8 -344.3 -273.2 -168.8 -174.3 -118.6 -78.91 -63.16 -55.72 -22.96 -26.89 -0.846 -2.01 -1.77 -4.39 -12.1 -9.94 -19.3 -6.01 -4.57 -1.5 -3.04 -3.09 -2.6 -2.5 -5.2 -3.6
Earnings Per Share (EPS) 3.07 3.1 0.16 0.089 -1.46 -2.63 -2.42 -1.96 -2.3 -1.91 -1.6 -1.38 -1.64 -0.81 -1.38 -0.44 15.68 -111.2 -170 -497.6 -453.6 -1,236 -615.6 -748.9 -347.7 -1,529 -13,339 -7,018 -8,750 -23,853 -17,391
Diluted Earnings Per Share 2.77 2.77 0.15 0.085 -1.46 -2.63 -2.42 -1.96 -2.3 -1.91 -1.6 -1.38 -1.64 -0.81 -1.38 -0.44 15.68 -111.2 -170 -497.6 -453.6 -1,236 -615.6 -748.9 -347.7 -1,529 -13,339 -7,018 -8,750 -23,853 -17,391
Weighted Average Shares Outstanding 143 144.3 145.3 142 135.4 132.2 115.3 88.37 75.47 62.07 49.04 45.65 34.07 25.41 13.11 1.93 0.04 0.025 0.025 0.024 0.021 0.015 0.01 0.008 0.004 0.001 0 0 0 0 0
Diluted Weighted Average Shares Outstanding 159.4 161.4 160.3 148.5 135.4 132.2 115.3 88.37 75.47 62.07 49.04 45.65 34.07 25.41 13.11 1.93 0.04 0.025 0.025 0.024 0.021 0.015 0.01 0.008 0.004 0.001 0 0 0 0 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program